Discussion
infarcts, diabetes
HYPERTENSION, DYSLIPIDEMIA, DIABETES
This study focuses on the investigation of colchicine and its benefit to reduce MMP-9, NOX-2, and TGF-β1 levels through ELISA test evaluation in stable STEMI patients. The demographic data of patients including age, gender, and risk factors such as hypertension, diabetes, dyslipidemia, smoker and ex-smoker, and also the large number of infarcts did not show the significant differences, so the results didn’t influence the distribution of patients in each group. The standard laboratory data like Hb, leukocyte, thrombocyte, BUN, Cr, AST, and ALT levels also did not show the significant differences between each group, so those standard markers didn’t influence the distribution and result in each group.